financetom
Business
financetom
/
Business
/
FAA administrator plans to meet with Boeing CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FAA administrator plans to meet with Boeing CEO
Nov 21, 2024 10:13 AM

WASHINGTON, Nov 21 (Reuters) - FAA Administrator Michael

Whitaker said on Thursday he plans to soon visit Boeing's ( BA )

Seattle offices to meet with CEO Kelly Ortberg.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
May 26, 2025
08:59 AM EDT, 05/05/2025 (MT Newswires) -- Consumer stocks leaned lower premarket Monday with the Consumer Staples Select Sector SPDR Fund (XLP) down 0.1% and the Consumer Discretionary Select Sector SPDR Fund (XLY) 0.7% lower recently. Tyson Foods ( TSN ) shares declined by nearly 2% even after the company reported higher fiscal Q2 adjusted earnings, while sales were flat...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Johnson & Johnson Says New Data Show Tremfya's Sustained Efficacy in Ulcerative Colitis
Johnson & Johnson Says New Data Show Tremfya's Sustained Efficacy in Ulcerative Colitis
May 26, 2025
08:59 AM EDT, 05/05/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday that new data from a phase 3 study of Tremfya, or guselkumab, showed its sustained clinical and endoscopic efficacy through week 92 in adults with moderately to severely active ulcerative colitis. The company said 72% of patients treated with Tremfya were in clinical remission, with...
Immutep Reports 'Excellent' Median Overall Survival in Efti-Keytruda Combo Trial; Shares Rise
Immutep Reports 'Excellent' Median Overall Survival in Efti-Keytruda Combo Trial; Shares Rise
May 26, 2025
08:58 AM EDT, 05/05/2025 (MT Newswires) -- Immutep ( IMMP ) said Monday that a phase 2b trial evaluating eftilagimod alfa in combination with Merck's ( MRK ) Keytruda to treat head and neck squamous cell cancer produced an excellent median overall survival result of 17.6 months. The firm said the result compares favorably with to historical results from the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved